#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	9918	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2138	457.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	561	C	551	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	9918	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2138	457.5	0	HET	.	.	.	C451T	.	451	451	C	676	676	C	552	C,T	287,249	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18780	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3438	539.7	0	.	n	.	0	T695C	SNP	695	695	T	969	969	C	551	C,T	530,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18780	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3438	539.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1912	1912	G	609	G,A	436,149	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18780	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3438	539.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2245	2245	C	610	C	588	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18780	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3438	539.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2319	2319	A	565	A	553	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18780	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3438	539.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2871	2871	C	533	C	513	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1300	folP	855	855	100.0	folP.l15.c4.ctg.1	1536	83.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1016	1018	AGC	127;128;128	A,G;G;C	121,1;123;122	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3520	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3377	103.1	1	SNP	p	S91F	1	.	.	271	273	TTC	571	573	TTC	127;127;130	T;T;C,G	122;121;122,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3520	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3377	103.1	1	SNP	p	D95G	1	.	.	283	285	GGC	583	585	GGC	124;124;125	G;G;C	118;118;117	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3520	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3377	103.1	1	SNP	p	G95N	0	.	.	283	285	GGC	583	585	GGC	124;124;125	G;G;C	118;118;117	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1052	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1259	82.8	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	108;110;111	G;G;C	106;108;109	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	614	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1017	59.6	0	.	n	.	0	A197.	DEL	197	197	A	641	641	A	143	A	142	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3472	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2878	119.4	1	SNP	p	D86N	0	.	.	256	258	GAC	529	531	GAC	130;132;134	G;A;C	124;118;129	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3472	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2878	119.4	1	SNP	p	S87R	1	.	.	259	261	CGT	532	534	CGT	134;136;138	C;G,A;T	128;129,1;131	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3472	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2878	119.4	1	SNP	p	R87W	0	.	.	259	261	CGT	532	534	CGT	134;136;138	C;G,A;T	128;129,1;131	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3472	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2878	119.4	1	SNP	p	R87I	0	.	.	259	261	CGT	532	534	CGT	134;136;138	C;G,A;T	128;129,1;131	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3472	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2878	119.4	1	SNP	p	S88P	0	.	.	262	264	TCC	535	537	TCC	138;136;138	T;C;C	130;128;130	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2696	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2712	98.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	126;123;122	G;G;C	124;118;116	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1267	1269	GCC	132;133;132	G,T;C;C	130,1;132;131	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1270	1272	ATG	132;133;132	A;T;G	130;131;132	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1282	1284	ACC	135;135;135	A;C;C	132;134;134	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1282	1284	ACC	135;135;135	A;C;C	132;134;134	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1783	1785	ACC	127;127;128	A,T;C;C	120,1;121;123	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1837	1839	GCG	117;119;119	G;C;G	113;114;112	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1837	1839	GCG	117;119;119	G;C;G	113;114;112	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1960	1962	GGT	88;86;86	G;G;T	81;80;78	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1969	1971	AGC	76;76;75	A;G;C	70;69;69	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2542	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2362	106.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1987	1989	CCG	61;64;66	C,G;C;G,A	58,1;60;57,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3928	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3177	122.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1628	1630	CCG	158;157;155	C;C;G	148;148;146	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1706	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1856	90.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	701	701	C	116	C	110	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	0	.	p	.	0	I45L	NONSYN	133	135	ATT	379	381	CTT	160;157;157	C,G;T;T	155,1;154;154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	0	.	p	.	0	G48E	NONSYN	142	144	GGA	388	390	GAA	160;159;160	G;A,G;A	159;157,1;159	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	895	897	GGT	149;151;154	G;G;T	145;147;145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	1	SNP	p	G120K	1	.	.	358	360	AAG	604	606	AAG	136;134;132	A,C;A;G,A	123,1;128;119,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	1	SNP	p	A121N	1	.	.	361	363	AAC	607	609	AAC	132;133;133	A;A;C	124;126;120	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1916	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1579	119.8	1	SNP	p	N121D	0	.	.	361	363	AAC	607	609	AAC	132;133;133	A;A;C	124;126;120	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6976	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4978	138.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	848	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	936	89.1	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	188;190;190	A;T;G	183;183;185	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
